Phase 2 Trial Defines Sunitinib Potential in Advanced Thyroid Cancer
While sunitinib failed as adjuvant treatment in advanced kidney cancer, this phase 2 study presented at the ongoing annual meeting of The Endocrine Society found that in patients with advanced thyroid cancer, sunitinib treatment resulted in median progression free survival of about 8 months. The authors think their results create sufficient evidence to initiate a phase 3 trial of the drug in thyroid cancer patients.
Kansas Considers Regulating Mental Health Drugs for Medicaid Patients
Kansas health regulators are working to repeal a 2002 law prohibiting the state from regulating mental health drugs used for treating Medicaid patients. Doing so could potentially save the state about $7 million.
Oncology Clinic or Hospital, How Do Patients Decide?
New oncology payment models, 340B pricing and disproportionate share hospitals, and the significant difference in reimbursement rates for cancer care services are just some of the challenges faced by community oncology clinics. How do patients make informed decisions on where to go for care?
The Expected Effect of Wearables on the Insurer-Consumer Relationship
While the wearable market itself has tremendous potential, its effect on the health insurance industry could be just as significant.
Americans Skeptical About Vaccines Remain Small Segment of Population
Despite the measles outbreak resulting from the anti-vaccination movement in the United States, the percent of Americans who said it’s "extremely important" to get children vaccinated continued to fall, according to a new Gallup poll.
Healthcare Faces a Digital Dilemma
In an era when most industries easily share big, complicated digital files, healthcare still leans hard on paper printouts and fax machines.
700 Physicians Form New ACO in Portland
A group of 700 independent Portland doctors, both primary care and specialty, have come together to for a new accountable care organization.
HHS Expanding Access Research
HHS has released a plan to expand how its agencies make research results freely available to scientists and the public.
Managed Care Minute: March 7, 2015
A one-minute look at managed care news during the week of March 2, 2015, including oral arguments for King v. Burwell and the approval of the first biosimilar in the United States.
California ED Forced to Close After EHR Failure
Antelope Valley Hospital in Lancaster, California, shut down its emergency department after the electronic health record and data system failed and the hospital had no backup plan in place.
CMS Has More Work to Do to Improve
The second open enrollment period for the Affordable Care Act went much smoother for consumers signing up for health plans through; however, CMS still has much work to do, according to a new report from the Government Accountability Office.
Study Underscores Harm From Unregulated Marketing of Genetic Tests
The study, conducted at the Dana-Farber Cancer Institute and published in the Journal of the National Cancer Institute found that the benefits of these personalized cancer products are reported much more frequently than are the limitations.
Healthcare Has Inefficient Approach to Cybersecurity
In a 3-month review of cyber risk management practices in healthcare, the Health Information Trust Alliance (HITRUST) has found that the industry's approach is reactive, inefficient, and labor intensive.
NIAID Trial to Evaluate Community-Based Hepatitis C Treatment
Gilead will be providing Harvoni free of cost to conduct a 600-person trial co-sponsored by the National Institute of Allergy and Infectious Diseases to evaluate if primary care physicians and other healthcare providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians.
Phase 3 Melanoma Trial Reports Better 5-Year Survival With Ipilimumab
The study, published in the Journal of Clinical Oncology found that the 5-year survival with ipilimumab (18.2%) was double that with placebo (8.8%) and roughly double the historical survival rate of patients with stage IV melanoma (approximately 10%).
FDA Approves First Biosimilar in US
Today the FDA approved the first biosimilar product in the United States. Zarxio (filgrastim-sndz), from Sandoz, Inc, is biosimilar to Amgen Inc’s Neupogen (filgrastim), which was first licensed in 1991.
Antidepressants Could Improve Cardiovascular Outcomes, Study Suggests
In patients with depression, antidepressants may be more important than statins, according to a study conducted at the Intermountain Medical Center Heart Institute in Salt Lake City, which will be presented at the American College of Cardiology's 64th Annual Scientific Session in San Diego.
AJMC Panelists Discuss How Discounts Should Expand HCV Treatment: “It Really Is Time to Treat Everyone”
A year after Sovaldi’s $1,000-a-pill price tag set off a national discussion, new entrants in the market to cure the hepatitis C virus have allowed pharmacy benefit managers to bring down its cost for health plans. Experts convened by The American Journal of Managed Care said this should expand who gets treatment, but they also say this won’t be last of the high-cost specialty drugs.
Encouraging Continued Participation in the Medicare Shared Savings Program
CMS has proposed several possible changes to the Medicare Shared Savings Program in an effort to attract new participants and to encourage current participants to continue with the program beyond their initial 3-year commitment.
Safety Net Hospitals Perform Well Even Without Medicaid Expansion
in some of the largest states that did not expand Medicaid, many safety-net hospitals fared pretty well last year—even better than in 2013 in many cases.
Twitter a Predictor of Insurance Exchange Enrollment
Twitter can be used as a real-time measurement of public sentiment for the Affordable Care Act (ACA) and the positivity and negativity of tweets could be used to determine state-level marketplace enrollment, according to researchers.
Outpatient Departments Treat Sicker, Costlier Patients Than Physician Offices
New proposals from Congress would decrease Medicare payments to hospital outpatient departments, which traditionally serve patients who are more likely to be minority, poorer, and have more severe chronic conditions compared with patients treated in physician offices.
New Guidelines for Treating Pediatric Hodgkin Lymphoma Issued
A guideline has been issued that outlines the use of 3-D computed tomography-based radiation therapy planning and volumetric image guidance to more effectively treat pediatric Hodgkin lymphoma and to reduce the radiation dose to normal tissue, thus decreasing the risk of late side effects.
NCI to Begin Search for a New Director
Harold Varmus, MD, who has led the National Cancer Institute at the National Institutes of Health for nearly 5 years, announced today that he will step down from his post, effective March 31, 2015.
State Medicaid Programs May Be Leaving Drug Rebates on the Table
A recent audit report out of New York serves as an example of state Medicaid programs that may not be maximizing their collection of revenue from drug rebates for Medicaid managed care enrollees.